CMTM4 and neoplasm: Indeed, we previously showed LLC and H292 control and CMTM4 KD tumor implanted in immuno-deficient mice grew in a similar rate in vivo (Appendix Fig. S8A,B), which demonstrated the importance of adaptive immunity, including T cells, in controlling CMTM4 KD tumor growth.